These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 38732103)
1. Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth. Drury J; Geisen ME; Tessmann JW; Rychahou PG; Kelson CO; He D; Wang C; Evers BM; Zaytseva YY Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732103 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress. Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393 [TBL] [Abstract][Full Text] [Related]
3. Dual regulation of fatty acid synthase (FASN) expression by O-GlcNAc transferase (OGT) and mTOR pathway in proliferating liver cancer cells. Raab S; Gadault A; Very N; Decourcelle A; Baldini S; Schulz C; Mortuaire M; Lemaire Q; Hardivillé S; Dehennaut V; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Panasyuk G; Lefebvre T Cell Mol Life Sci; 2021 Jul; 78(13):5397-5413. PubMed ID: 34046694 [TBL] [Abstract][Full Text] [Related]
4. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356 [TBL] [Abstract][Full Text] [Related]
5. GFPT1 accelerates immune escape in breast cancer by modifying PD-L1 via O-glycosylation. Tang W; Gao Y; Hong S; Wang S BMC Cancer; 2024 Aug; 24(1):1071. PubMed ID: 39210323 [TBL] [Abstract][Full Text] [Related]
9. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer. Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967 [TBL] [Abstract][Full Text] [Related]
10. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma. Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624 [TBL] [Abstract][Full Text] [Related]
11. Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1). Chen Q; Müller JS; Pang PC; Laval SH; Haslam SM; Lochmüller H; Dell A Biomolecules; 2015 Oct; 5(4):2758-81. PubMed ID: 26501342 [TBL] [Abstract][Full Text] [Related]
12. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling. Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217 [TBL] [Abstract][Full Text] [Related]
13. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436 [TBL] [Abstract][Full Text] [Related]
15. OGT Controls the Expression and the Glycosylation of E-cadherin, and Affects Glycosphingolipid Structures in Human Colon Cell Lines. Biwi J; Clarisse C; Biot C; Kozak RP; Madunic K; Mortuaire M; Wuhrer M; Spencer DIR; Schulz C; Guerardel Y; Lefebvre T; Vercoutter-Edouart AS Proteomics; 2019 Nov; 19(21-22):e1800452. PubMed ID: 31373757 [TBL] [Abstract][Full Text] [Related]
16. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation. Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506 [No Abstract] [Full Text] [Related]
17. Removal of O-GlcNAcylation is important for pig preimplantation development. Shibutani M; Mori T; Miyano T; Miyake M J Reprod Dev; 2015; 61(4):341-50. PubMed ID: 26004176 [TBL] [Abstract][Full Text] [Related]
18. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer. Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909 [TBL] [Abstract][Full Text] [Related]
19. O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. Wu N; Jiang M; Han Y; Liu H; Chu Y; Liu H; Cao J; Hou Q; Zhao Y; Xu B; Xie X J Cell Mol Med; 2019 Feb; 23(2):1354-1362. PubMed ID: 30484950 [TBL] [Abstract][Full Text] [Related]
20. Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation. Liu X; Blaženović I; Contreras AJ; Pham TM; Tabuloc CA; Li YH; Ji J; Fiehn O; Chiu JC Nat Commun; 2021 Jul; 12(1):4173. PubMed ID: 34234137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]